Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zagociguat by Tisento Therapeutics for Vascular Dementias: Likelihood of Approval
Zagociguat is under clinical development by Tisento Therapeutics and currently in Phase I for Vascular Dementias. According to GlobalData, Phase...